NYSE:DLBDolby Laboratories Stock Price, Forecast & News

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DLB stock has increased by 16.5% and is now trading at $70.17.
View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Dolby Laboratories.

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Dolby Laboratories.

Dolby Laboratories, Inc. (NYSE:DLB) issued its quarterly earnings data on Monday, August, 3rd. The electronics maker reported $0.86 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.13 by $0.73. The electronics maker had revenue of $246.91 million for the quarter, compared to analysts' expectations of $232.61 million. Dolby Laboratories had a net margin of 20.89% and a return on equity of 10.67%. The business's revenue was down 18.3% on a year-over-year basis. During the same quarter last year, the business earned $0.76 earnings per share.
View Dolby Laboratories' earnings history.

Dolby Laboratories declared a quarterly dividend on Tuesday, August 4th. Investors of record on Monday, August 17th will be given a dividend of $0.22 per share on Wednesday, August 26th. This represents a $0.88 annualized dividend and a dividend yield of 1.25%. The ex-dividend date is Friday, August 14th.
View Dolby Laboratories' dividend history.

Dolby Laboratories issued an update on its fourth quarter earnings guidance on Monday, August, 3rd. The company provided earnings per share (EPS) guidance of $0.22-0.37 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.42. The company issued revenue guidance of $225-255 million, compared to the consensus revenue estimate of $251.94 million.

5 Wall Street analysts have issued 1-year target prices for Dolby Laboratories' stock. Their forecasts range from $65.00 to $83.00. On average, they expect Dolby Laboratories' share price to reach $73.67 in the next year. This suggests a possible upside of 5.0% from the stock's current price.
View analysts' price targets for Dolby Laboratories.

Press coverage about DLB stock has been trending negative this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Dolby Laboratories earned a daily sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the electronics maker a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about Dolby Laboratories.

Dolby Laboratories saw a drop in short interest in July. As of July 31st, there was short interest totaling 1,240,000 shares, a drop of 13.9% from the July 15th total of 1,440,000 shares. Based on an average daily trading volume, of 422,700 shares, the days-to-cover ratio is presently 2.9 days. Currently, 1.9% of the company's shares are short sold.
View Dolby Laboratories' Short Interest.

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Vishay Intertechnology (VSH) and Rogers (ROG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include Metlife (MET), AT&T (T), Netflix (NFLX), Comcast (CMCSA), Walt Disney (DIS), Activision Blizzard (ATVI), Brighthouse Financial (BHF), InterDigital Wireless (IDCC), Las Vegas Sands (LVS) and Hasbro (HAS).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a number of institutional and retail investors. Top institutional investors include Marathon Asset Management LLP (0.79%), Obermeyer Wood Investment Counsel Lllp (0.60%), Trinity Street Asset Management LLP (0.50%), Sumitomo Mitsui Trust Holdings Inc. (0.48%), New York State Common Retirement Fund (0.43%) and KAMES CAPITAL plc (0.29%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Sumitomo Mitsui Trust Holdings Inc., UBS Group AG, Trinity Street Asset Management LLP, Stone Ridge Asset Management LLC, NN Investment Partners Holdings N.V., Unigestion Holding SA, and NN Investment Partners Holdings N.V.. Company insiders that have sold Dolby Laboratories company stock in the last year include Avadis Tevanian, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Ryan Nicholson, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories.

DLB stock was acquired by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, Marathon Asset Management LLP, Obermeyer Wood Investment Counsel Lllp, Seizert Capital Partners LLC, Pembroke Management LTD, WINTON GROUP Ltd, Swiss National Bank, and Naples Global Advisors LLC.
View insider buying and selling activity for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $70.17.

Dolby Laboratories has a market capitalization of $7.06 billion and generates $1.24 billion in revenue each year. The electronics maker earns $255.15 million in net income (profit) each year or $2.44 on an earnings per share basis. Dolby Laboratories employs 2,193 workers across the globe.

The official website for Dolby Laboratories is www.dolby.com.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]